Nemonoxacin: First Global Approval

The aetiology and antibiotic management of community-acquired pneumonia in adults in Europe: a literature review

(2014) A. Torres et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Nemonoxacin (TG-873870) for treatment of community-acquired pneumonia

(2014) Chung-Chih Lai et al.   Expert Review of Anti-Infective Therapy

Etiologies and Resistance Profiles of Bacterial Community-Acquired Pneumonia in Cambodian and Neighboring Countries’ Health Care Settings: A Systematic Review (1995 to 2012)

(2014) Sophie Goyet et al.   PLoS One

The bacterial aetiology of adult community-acquired pneumonia in Asia: a systematic review

(2014) Leon Peto et al.   TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE

In VitroActivity of Nemonoxacin, a Novel Nonfluorinated Quinolone Antibiotic, against Chlamydia trachomatis and Chlamydia pneumoniae

(2013) Kobkul Chotikanatis et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pharmacokinetics and Pharmacodynamics of Nemonoxacin against Streptococcus pneumoniae in anIn VitroInfection Model

(2013) Wang Liang et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Characterizations of Clinical Isolates of Clostridium difficile by Toxin Genotypes and by Susceptibility to 12 Antimicrobial Agents, Including Fidaxomicin (OPT-80) and Rifaximin: a Multicenter Study in Taiwan

(2012) Chun-Hsing Liao et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Safety and Clinical Pharmacokinetics of Nemonoxacin, a Novel Non-Fluorinated Quinolone, in Healthy Chinese Volunteers Following Single and Multiple Oral Doses

(2012) Beining Guo et al.   CLINICAL DRUG INVESTIGATION

Improving known classes of antibiotics: an optimistic approach for the future

(2012) Karen Bush   CURRENT OPINION IN PHARMACOLOGY

Multicenter Study in Taiwan of theIn VitroActivities of Nemonoxacin, Tigecycline, Doripenem, and Other Antimicrobial Agents against Clinical Isolates of Various Nocardia Species

(2011) Chih-Cheng Lai et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antimicrobial Susceptibilities and Molecular Epidemiology of Clinical Isolates ofClostridium difficilein Taiwan

(2011) Yi-Chun Lin et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Efficacy and Safety of Nemonoxacin versus Levofloxacin for Community-Acquired Pneumonia

(2010) D. J. J. van Rensburg et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Comparative In Vitro Activities of Nemonoxacin (TG-873870), a Novel Nonfluorinated Quinolone, and Other Quinolones against Clinical Isolates

(2010) T.-L. Lauderdale et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In vivo antibacterial activity of nemonoxacin, a novel non-fluorinated quinolone

(2010) C.-R. Li et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Multiple-Dose Safety, Tolerability, and Pharmacokinetics of Oral Nemonoxacin (TG-873870) in Healthy Volunteers

(2009) D. T. Chung et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Nemonoxacin (TG-873870), a Novel Potent Broad-Spectrum Nonfluorinated Quinolone, in Healthy Volunteers

(2009) L. Lin et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In Vitro Activity of Nemonoxacin, a Novel Nonfluorinated Quinolone, against 2,440 Clinical Isolates

(2009) H. J. Adam et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Comparative in vitro activities of the new quinolone nemonoxacin (TG-873870), gemifloxacin and other quinolones against clinical isolates of Mycobacterium tuberculosis

(2009) C.-K. Tan et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Comparative in vitro activities of nemonoxacin, doripenem, tigecycline and 16 other antimicrobials against Nocardia brasiliensis, Nocardia asteroides and unusual Nocardia species

(2009) Chih-Cheng Lai et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan

(2009) Y.-H. Chen et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY